Roberto Labianca - Concepedia

Author

Roberto Labianca

Azienda Ospedaliero Universitaria Ospedali Riuniti ORCID

Also Known As

Alberto Sobrero, Aron Goldhirsch, F Puglisi, Giancarlo Martignoni, Labianca, R, Michela Libertini, R LABIANCA, R Labianca, R. LaBianca, R. Labianca

550

Publications

38.8K

Citations

H-Index

114

Concepts

All Affiliations

Azienda Ospedaliero Universitaria Ospedali Riuniti Mario Negri Institute for Pharmacological Research Ospedale Papa Giovanni XXIII Istituti di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino

About

Roberto Labianca is an author at Azienda Ospedaliero Universitaria Ospedali Riuniti specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	56	130	19K
2	Health Sciences	23	33	1.5K
3	Public Health	4	4	96
4	Nursing	1	1	199
5	Allergy	1	1	13

Roberto Labianca

207

Publications

32.8K

Citations

H-Index

Page 1

	Year	Citations
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Eric Van Cutsem, Andrés Cervantes, René Adam, Annals of Oncology Surgical OncologyEsmo Consensus GuidelinesGastrointestinal OncologyMedicineCancer Management	2016	3.3K
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer Daniel J. Sargent, Silvia Marsoni, Geneviève Monges, Journal of Clinical Oncology	2010	1.6K
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein, Annals of Oncology Esmo Consensus GuidelinesPersonalized ApproachGastrointestinal OncologyColorectal SurgeryMedicine	2012	1.5K
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Roberto Labianca, Bernard Nordlinger, Giordano Beretta, Annals of Oncology Surgical OncologyGastrointestinal OncologyColorectal SurgeryMedicineGastroenterology	2013	1.4K
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Guillem Argilés, Josep Tabernero, Roberto Labianca, Annals of Oncology Gastrointestinal OncologyColorectal SurgeryMedicineCancer ManagementGastroenterology	2020	1.2K
Prognostic Role of <i>KRAS</i> and <i>BRAF</i> in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial Arnaud Roth, Sabine Tejpar, Mauro Delorenzi, Journal of Clinical Oncology	2009	1.1K
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer Axel Grothey, Alberto Sobrero, Anthony F. Shields, New England Journal of Medicine	2018	1.1K
Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent, Journal of Clinical Oncology	2004	1K
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer Philippe Rougier, Eric Van Cutsem, Emilio Bajetta, The Lancet Gastrointestinal OncologyMedicineColorectal CancerFluorouracil FailurePharmacotherapy	1998	992
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients Daniel J. Sargent, Richard M. Goldberg, Stacy D. Jacobson, New England Journal of Medicine	2001	986

Page 1